Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drugs and polypharmacy].

S Alusík1

  • 1I. interní klinika Fakultní nemocnice Královské Vinohrady, Praha.

Vnitrni Lekarstvi
|January 12, 2005
PubMed
Summary

Polypharmacy, the concurrent use of multiple medications, is rising in the Czech Republic due to complex factors. This analysis explores solutions involving drug manufacturers, physicians, patients, and pharmacists to mitigate polypharmacy challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin: the past, presence, and future.

Minerva medica·2014
Same author

Bilateral oophorectomy may have an unfavorable effect on glucose metabolism compared with natural menopause.

Physiological research·2014
Same author

Natural postmenopause is associated with an increase in combined cardiovascular risk factors.

Physiological research·2012
Same author

The effect of selected pre-analytical phase variables on plasma thromboxane A₂ measurements in humans.

International journal of laboratory hematology·2012
Same author

The inhibitory effect of statins on urinary 11-dehydrothromboxane levels.

International angiology : a journal of the International Union of Angiology·2010
Same author

Menopause: clustering of metabolic syndrome components and population changes in insulin resistance.

Climacteric : the journal of the International Menopause Society·2010

Area of Science:

  • Pharmacology
  • Public Health
  • Health Policy

Context:

  • Increasing polypharmacy presents significant challenges in the Czech Republic.
  • Analysis of contributing factors from various stakeholders including drug manufacturers, physicians, patients, and the state.

Purpose:

  • To investigate the causes of escalating polypharmacy.
  • To analyze the attitudes of key stakeholders towards polypharmacy.
  • To identify potential strategies for polypharmacy reduction.

Summary:

  • The study examines the multifaceted causes of increased polypharmacy in the Czech Republic.
  • It critically analyzes the roles and perspectives of drug manufacturers, healthcare providers, patients, and governmental health policies.
  • Potential interventions and solutions for reducing polypharmacy are discussed, highlighting the pharmacist's role.

Impact:

  • Provides insights into the complex issue of polypharmacy.
  • Informs health policy and clinical practice for medication management.
  • Suggests avenues for optimizing pharmacotherapy and patient outcomes.

Related Experiment Videos